Q3 2019 13F Holders as of 9/30/2019
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
106M
-
Number of holders
-
325
-
Total 13F shares, excl. options
-
72.6M
-
Shares change
-
+1.76M
-
Total reported value, excl. options
-
$5.47B
-
Value change
-
-$253M
-
Put/Call ratio
-
1.1
-
Number of buys
-
187
-
Number of sells
-
-187
-
Price
-
$75.32
Significant Holders of Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) as of Q3 2019
472 filings reported holding SRPT - Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q3 2019.
Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) has 325 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 72.6M shares
of 106M outstanding shares and own 68.77% of the company stock.
Largest 10 shareholders include FMR LLC (8.06M shares), VANGUARD GROUP INC (6.37M shares), BlackRock Inc. (4.51M shares), SANDS CAPITAL MANAGEMENT, LLC (3.95M shares), PRICE T ROWE ASSOCIATES INC /MD/ (3.79M shares), JANUS HENDERSON GROUP PLC (2.31M shares), FIL Ltd (2.25M shares), STATE STREET CORP (2.19M shares), Invesco Ltd. (1.82M shares), and ADAGE CAPITAL PARTNERS GP, L.L.C. (1.72M shares).
This table shows the top 325 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.